Cancer Therapeutic Resistance: Progress and Perspectives (April 7-8, 2016 – Barcelona, Spain)

Drugs Today (Barc). 2016 Jun;52(6):347-54. doi: 10.1358/dot.2016.52.6.2515960.

ABSTRACT

At the Cancer Therapeutic Resistance: Progress and Perspectives conference, in Barcelona, Spain, April 7-8, 2016, researchers, clinicians and students gathered to discuss our current understanding of intrinsic and acquired resistance of tumors to cancer therapies and to explore how to translate strategies to predict risk or overcome resistance to the clinic. The sessions covered a wide range of topics, including cancer omics, molecular classification, clinically relevant tumor models, biomarkers and novel therapeutic targets, and personalized medicine, with talks from many international experts in the field. This report highlights the main presentations that demonstrate the progress being made in predicting and identifying drug resistance in patients with cancer, personalized approaches to direct treatment and understanding the mechanisms involved. With better models of human cancer and powerful high-throughput screening techniques, translation to the clinic leading to tangible benefits for patients is attainable.

PMID:27458611 | DOI:10.1358/dot.2016.52.6.2515960